SC42619 free base
SC42619 free base is a selective platelet thrombin receptor (thrombin receptor) antagonist. SC42619 free base inhibits thrombin-induced platelet aggregation, secretion, calcium influx, and phosphatidic acid phosphorylation, as well as trypsin-induced platelet aggregation. SC42619 free base reduces the content of individual platelets. SC42619 free base inhibits prostacyclin (PGI2) synthesis in endothelial cells. SC42619 free base can be used for the research of hematological diseases.
For research use only. We do not sell to patients.
- CAS No.: 107534-95-2
- Formula: C15H28N2O3
- Molecular Weight:284.39
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Calcium Channel Isoforms
More
Biological Activity
Description
In Vitro
SC42619 (0.2-3 mM; 120 s) free base acts as a competitive antagonist of thrombin receptors on washed human platelets, with a pA2 value of 2.93. Under the condition of 2 nM Thrombin (HY-114164), it completely inhibits Thrombin-induced aggregation, with an IC50 of 425 μM. It also slightly enhances aggregation induced by non-saturating concentrations of U-46619 (HY-108566) in human platelet-rich plasma, and slightly reduces the count of individual platelets, with an EC50 of approximately 0.2 mM[1].
SC42619 free base competitively inhibits thrombin-induced ATP secretion in washed human platelets[1].
SC42619 (1 mM; 120 s) free base competitively inhibits Thrombin-induced intracellular Ca2+ mobilization when the extracellular Ca2+ concentration is <0.1 μM; it non-competitively inhibits Thrombin-induced cytoplasmic Ca2+ elevation when the extracellular Ca2+ concentration is 1 mM; and it inhibits ADP (HY-W010918)-induced cytoplasmic Ca2+ elevation only when the extracellular Ca2+ concentration is 1 mM[1].
SC42619 (5 mM; 120 s) free base inhibits Mn2+ influx in washed human platelets induced by Thrombin and ADP[1].
SC42619 (0-3 mM; 120 s) free base inhibits thrombin-induced 32P incorporation into phosphatidic acid in the presence of 2.5 nM thrombin, with an IC50 of 0.22 mM[1].
Co-incubation with SC42619 (5 mM; 30 min) free base and 5 nM Thrombin reduces Thrombin-induced glycoprotein V hydrolysis by approximately 50%[1].
SC42619 (0.42-5 mM; 2 min) free base potently and selectively inhibits washed human platelet aggregation induced by 2 nM Thrombin, with an IC50 of 0.42 mM[2].
SC42619 (0.5-5 mM; 2 min) free base selectively inhibits thrombin- and Trypsin (HY-129047)-induced PGI2 synthesis in human umbilical vein endothelial cells, with an IC50 of 0.5 mM against 3 nM thrombin. It enhances Histamine (HY-B1204)- or Bradykinin (HY-P0206)-induced PGI2 synthesis, and its inhibitory effect on thrombin-induced synthesis cannot be reversed by increasing the concentration of thrombin[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 107534-95-2
-
Molecular Weight 284.39
-
Formula C15H28N2O3
-
SMILES
O=C(N1CCCC1)[C@H](CC(C)C)N[C@H](C)C(OCC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- SC42619
- 107534-95-2
- SC 42619
- SC-42619
- Protease Activated Receptor (PAR)
- Thrombin
- Calcium Channel
- ADP
- phosphatidic acid phosphorylation
- platelet thrombin receptor
- human umbilical vein endothelial cells
- collagen
- prostacyclin synthesis
- calcium influx
- platelet aggregation
- human platelets
- vasopressin
- Inhibitor
- inhibitor
- inhibit